Oxford Cannabinoid Technologies Holdings (OCTP) RNS Announcements

Add to Alert list
Date Time Source Announcement
13 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
07 Mar 2023 11:05 AM
RNS
Second Price Monitoring Extn
07 Mar 2023 11:00 AM
RNS
Price Monitoring Extension
06 Mar 2023 11:05 AM
RNS
Second Price Monitoring Extn
06 Mar 2023 11:00 AM
RNS
Price Monitoring Extension
25 Jan 2023 12:09 PM
RNS
Holding in Company
23 Jan 2023 07:00 AM
RNS
Half-year Report
16 Jan 2023 07:00 AM
RNS
Appointment of General Counsel & Notice of Results
12 Jan 2023 07:00 AM
RNS
Update on combined Clinical Trial Application
05 Jan 2023 10:46 AM
RNS
Submission of combined Clinical Trial Application
04 Jan 2023 02:05 PM
RNS
Second Price Monitoring Extn
04 Jan 2023 02:00 PM
RNS
Price Monitoring Extension
04 Jan 2023 11:05 AM
RNS
Second Price Monitoring Extn
04 Jan 2023 11:00 AM
RNS
Price Monitoring Extension
03 Jan 2023 11:05 AM
RNS
Second Price Monitoring Extn
03 Jan 2023 11:00 AM
RNS
Price Monitoring Extension
29 Dec 2022 04:40 PM
RNS
Second Price Monitoring Extn
29 Dec 2022 04:35 PM
RNS
Price Monitoring Extension
15 Dec 2022 02:42 PM
RNS
Director/PDMR Shareholding
15 Dec 2022 12:30 PM
EQS
Proactive research analyst John Savin on Oxford...
15 Dec 2022 09:36 AM
EQS
Oxford Cannabinoid Technologies 'very confident...
12 Dec 2022 07:00 AM
RNS
Trading Update
05 Dec 2022 02:38 PM
EQS
Oxford Cannabinoid Technologies appoints new CEO
05 Dec 2022 07:00 AM
RNS
Directorate Change
15 Nov 2022 03:22 PM
EQS
Oxford Cannabinoid Technologies nearly ready fo...
15 Nov 2022 11:28 AM
RNS
Holding(s) in Company
11 Nov 2022 11:05 AM
RNS
Second Price Monitoring Extn
11 Nov 2022 11:00 AM
RNS
Price Monitoring Extension
17 Oct 2022 07:00 AM
RNS
Directorate Change
28 Sep 2022 01:04 PM
RNS
Result of AGM
28 Sep 2022 07:00 AM
RNS
Appointment of finnCap Ltd. as Corporate Broker
31 Aug 2022 07:00 AM
RNS
Notice of AGM
26 Aug 2022 07:00 AM
RNS
Strategic Budget Review & Directorate Change
15 Aug 2022 07:00 AM
RNS
Inaugural Meeting of Scientific Advisory Board
04 Aug 2022 07:00 AM
RNS
Filing of 2022 Annual Report & Accounts
03 Aug 2022 11:05 AM
RNS
Second Price Monitoring Extn
03 Aug 2022 11:00 AM
RNS
Price Monitoring Extension
25 Jul 2022 07:00 AM
RNS
2022 Final Results
20 Jul 2022 07:00 AM
RNS
Notice of Results
20 Jul 2022 07:00 AM
RNS
MSA and Work Order with Simbec Research
29 Jun 2022 07:00 AM
RNS
Trading Update
30 May 2022 04:40 PM
RNS
Second Price Monitoring Extn
30 May 2022 04:35 PM
RNS
Price Monitoring Extension
16 May 2022 07:00 AM
RNS
New Broker and Investor Presentation
25 Apr 2022 07:00 AM
RNS
Formation of Scientific Advisory Board
06 Apr 2022 12:58 PM
RNS
Results of Requisitioned General Meeting
01 Apr 2022 07:00 AM
RNS
Registered Office Address Change
31 Mar 2022 07:00 AM
RNS
Updates on Lead Programme 1 and Programme 2
11 Mar 2022 10:00 AM
RNS
Posting of Circular & Notice of GM
10 Mar 2022 11:34 AM
RNS
Holding in Company

Oxford Cannabinoid Technologies Holdings is a clinical stage biopharmaceutical company focused on the development and commercialisation of innovative cannabinoid medicines. In May 2024 it announced that it applied to the Financial Conduct Authority and London Stock Exchange plc to effect a cancellation of listing of its ordinary shares on the Standard segment of the FCA's Official List and trading on the Main Market for listed securities of the LSE.

Oxford Cannabinoid Technologies Holdings was listed in London under the ticker OCTP.

UK 100

Latest directors dealings